MENU
+Compare
LENZ
Stock ticker: NASDAQ
AS OF
Mar 11, 04:59 PM (EDT)
Price
$22.92
Change
+$0.34 (+1.51%)
Capitalization
622.9M

LENZ LENZ Therapeutics Forecast, Technical & Fundamental Analysis

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products... Show more

LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for LENZ with price predictions
Mar 10, 2025

LENZ's RSI Oscillator recovers from oversold territory

The RSI Oscillator for LENZ moved out of oversold territory on March 05, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 19 similar instances when the indicator left oversold territory. In of the 19 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 51 cases where LENZ's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on March 07, 2025. You may want to consider a long position or call options on LENZ as a result. In of 70 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for LENZ just turned positive on March 06, 2025. Looking at past instances where LENZ's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LENZ advanced for three days, in of 204 cases, the price rose further within the following month. The odds of a continued upward trend are .

LENZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LENZ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for LENZ entered a downward trend on March 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.894) is normal, around the industry mean (11.729). P/E Ratio (0.000) is within average values for comparable stocks, (64.632). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (235.265).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly better than average price growth. LENZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LENZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

LENZ is expected to report earnings to rise 279.17% to -91 cents per share on March 25

LENZ Therapeutics LENZ Stock Earnings Reports
Q4'23
Est.
$-0.91
Q3'23
Est.
$-0.24
Q2'23
Missed
by $5.82
Q1'23
Missed
by $2.61
Q4'22
Missed
by $2.59
The last earnings report on November 08 showed earnings per share of -23 cents, meeting the estimate of -23 cents. With 200.07K shares outstanding, the current market capitalization sits at 622.90M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
445 Marine View Avenue
Phone
+1 858 925-7000
Employees
N/A
Web
https://www.lenz-tx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LAFAX27.15N/A
N/A
Columbia Acorn International Sel A
MMDEX46.44N/A
N/A
Praxis Growth Index I
LIGYX11.16N/A
N/A
Loomis Sayles International Growth Y
WLGCX23.32N/A
N/A
Macquarie Large Cap Growth Fund C
FZIPX12.96N/A
N/A
Fidelity ZERO Extended Market Index

LENZ and Stocks

Correlation & Price change

A.I.dvisor tells us that LENZ and DNTH have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LENZ and DNTH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LENZ
1D Price
Change %
LENZ100%
-4.35%
DNTH - LENZ
28%
Poorly correlated
+1.38%
MIST - LENZ
28%
Poorly correlated
+0.54%
OCGN - LENZ
28%
Poorly correlated
-8.82%
TCRX - LENZ
27%
Poorly correlated
-6.06%
DSGN - LENZ
25%
Poorly correlated
-0.71%
More